AI assistant
Sending…
Kintor Pharmaceutical Limited — Governance Information 2021
Apr 30, 2021
51183_rns_2021-04-30_41a2f5dd-1e35-418a-b07b-1839c81c7729.pdf
Governance Information
Open in viewerOpens in your device viewer
==> picture [58 x 59] intentionally omitted <==
**開拓藥業有限公司 ***
KINTOR PHARMACEUTICAL LIMITED
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 9939)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
The members of the board of directors (the “ Board ”) of KINTOR PHARMACEUTICAL LIMITED are set out below.
Executive Director
Dr. Youzhi Tong
Non-executive Directors
Mr. Gang Lu
Mr. Jie Chen
Dr. Yan Wang
Mr. Wei Zhang
Ms. Yaling Wu
Independent Non-executive Directors
Dr. Michael Min Xu
Mr. Wallace Wai Yim Yeung Prof. Liang Tong
1
The Board has 3 Board Committees. The table below provides membership information of these committees on which each Director serves.
| Board CommitteeDirectors | AuditCommittee | RemunerationCommittee | NominationCommittee |
|---|---|---|---|
| Dr. Youzhi Tong | M | C | |
| Mr. Gang Lu | |||
| Mr. Jie Chen | |||
| Dr. Yan Wang | M | ||
| Mr. Wei Zhang | |||
| Ms. Yaling Wu | |||
| Dr. Michael Min Xu | M | C | M |
| Mr. Wallace Wai Yim Yeung | C | M | |
| Prof. Liang Tong | M |
Notes:
-
C Chairman of the relevant Board Committees
-
M Member of the relevant Board Committees
-
For identification purpose only
April 30, 2021
2
More from Kintor Pharmaceutical Limited
Director's Dealing
2026
May 28
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 26
Regulatory Filings
2026
May 6
Environmental & Social Information
2026
Apr 29
Annual Report
2026
Apr 29
Capital/Financing Update
2026
Apr 20